Exact Sciences (EXAS)
(Delayed Data from NSDQ)
$42.93 USD
-1.74 (-3.90%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $42.92 -0.01 (-0.02%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Exact Sciences Corporation [EXAS]
Reports for Purchase
Showing records 301 - 320 ( 366 total )
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
UPDATE ON COLOGUARD CLINICAL TRIAL & MARKETING STRATEGY-BUY
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
1Q12 Financial Preview - Pivotal Study Likely on Track - Color on Product Extensions & Commercial Strategy Could Be Positive - Reaffirming OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
COMPETITIVE VALIDATION STUDY DATA DOESN''T MEASURE UP - BUY
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Reaffirming OUTPERFORM - Competitive Cloud Lifted Following Weak Epigenomics Data
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
3Q11 Results Review: Timelines on Track; Additional Validation Date Imminent
Provider: AURIGA USA
Analyst: MCDONALD P
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Exact Sciences Corporation
Industry: Medical - Biomedical and Genetics
3Q11 Recap -Reaffirming OUTPERFORM - Clinical Trial Enrollment on Track, Instrument Development Above Plan & Validation Data Expected Soon
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z